N/A
Manufactured by Advagen Pharma Ltd
1,986 FDA adverse event reports analyzed
Last updated: 2026-04-15
CHLORPROMAZINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Advagen Pharma Ltd. The most commonly reported adverse reactions for CHLORPROMAZINE HYDROCHLORIDE include TOXICITY TO VARIOUS AGENTS, DRUG INEFFECTIVE, OVERDOSE, OFF LABEL USE, DRUG INTERACTION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHLORPROMAZINE HYDROCHLORIDE.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,986 FDA FAERS reports that mention CHLORPROMAZINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include TOXICITY TO VARIOUS AGENTS, DRUG INEFFECTIVE, OVERDOSE, OFF LABEL USE, DRUG INTERACTION, NEUROLEPTIC MALIGNANT SYNDROME. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Advagen Pharma Ltd in connection with CHLORPROMAZINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.